Abstract:Cancer cells employ bidirectional cell communication to maintain growth and metastasis in the tumor microenvironment. One mechanism of communication that has become increasingly appreciated is the secretion of extracellular vesicles (EVs), heterogeneous multi-signal messengers that support cancer dissemination through the transfer of biomolecules such as oncoproteins and noncoding RNA species. However, little is understood about EVs in relation to chemotherapy resistance. In this study, we profiled two different breast cancer cell lines: 1) BT549 (triple negative), treated with gemcitabine and paclitaxel chemotherapy, and 2) MCF7 (estrogen receptor-positive), treated with palbociclib and fulvestrant, compared to their wild-type states. EVs were collected from these cells using tangential flow filtration and quantified with Brownian motion-based nanoparticle tracking analysis and microfluidic resistive pulse sensing, and profiling of RNA and peptide markers was completed through RT-qPCR and Western blotting, respectively. Initial data showed that representative mitochondrial ribosomal genes mt12S and MRPS14 were among the most upregulated RNAs in our drug-exposed EV samples, indicating that extracellular transfer of mitochondrial materials plays a role in cancer growth under chemotherapy stress. These findings were supported by prior genetic research at the Vasudevan laboratory, in which a set of mitochondrial ribosomal RNAs was found to be upregulated in cytosine arabinoside-induced chemoresistant acute monocytic leukemia cells, as well as by the recent discovery of mitovesicles, a novel population of EVs that originate from mitochondria. Through additional efforts to isolate further subtypes of EVs, the mechanisms by which these mitochondrial cargoes promote chemoresistant phenotypes will be uncovered. Citation Format: Harrison Ngue, Hyejin Kim, Shobha Vasudevan. Characterizing cargoes of extracellular vesicles in promoting breast cancer growth and chemotherapy resistance [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 5829.

A Novel Model of Cancer Drug Resistance: Oncosomal Release of Cytotoxic and Antibody-Based Drugs

Extracellular vesicles in anti-tumor drug resistance: Mechanisms and therapeutic prospects

Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications

Exosomes: A New Pathway for Cancer Drug Resistance

Exosome Mediated Multidrug Resistance in Cancer.

The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance

Acquisition of drug resistance in endothelial cells by tumor-derived extracellular vesicles and cancer progression

Extracellular Vesicles in Cancer Drug Resistance: Implications on Melanoma Therapy

The Role of Intracellular and Extracellular Vesicles in the Development of Therapy Resistance in Cancer

Intercellular transfer of multidrug resistance mediated by extracellular vesicles

Extracellular vesicles in the tumor microenvironment: old stories, but new tales

Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance

Extracellular Vesicles: New Classification and Tumor Immunosuppression

Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistance

Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors

Abstract 5829: Characterizing cargoes of extracellular vesicles in promoting breast cancer growth and chemotherapy resistance

Extracellular Vesicles as Drug Targets and Delivery Vehicles for Cancer Therapy

Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancers

The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond

Tumor immune escape: extracellular vesicles roles and therapeutics application

The application of extracellular vesicles in colorectal cancer metastasis and drug resistance: recent advances and trends